Harnessing nanotechnology for efficient delivery of indole-based drugs in cancer treatment
Cancer Treatment and Research Communications · 2025 · 45 · 101019
DOI: 10.1016/j.ctarc.2025.101019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2025. Verfasst von Nutan Shukla und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia. Electronic address: nutanshukla14@gmail.com. Hauptthemen laut MEDLINE: Indoles, Neoplasms, Antineoplastic Agents, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Southern Federal University.
Abstract (Originalsprache)
Indole-based compounds represent an important class of bioactive molecules with proven anticancer potential. However, their clinical translation is hindered by poor solubility, rapid metabolism, systemic toxicity, and limited tumor penetration. Nanotechnology offers promising strategies to overcome these pharmacological and physiological barriers. In this review, we critically evaluate the challenges associated with indole drug delivery and discuss how nanocarrier systems-including liposomes, polymeric nanoparticles, dendrimers, and inorganic platforms-enhance solubility, stability, bioavailability, and tumor selectivity. Special attention is given to tumor extracellular matrix (oncomatrix) properties, which modulate immune evasion and drug diffusion. We also provide a comparative analysis of different nanocarrier platforms, highlighting their advantages, limitations, and translational potential. Finally, future perspectives emphasize the development of barrier-adaptive, stimuli-responsive, and clinically translatable nanomedicines to fully realize the therapeutic promise of indole derivatives in precision oncology. .Emphasis is placed on the strategies for improving tumor-targeting efficiency, stimuli-responsive release, and overcoming biological barriers such as the tumor extracellular matrix and multidrug resistance. Furthermore, we evaluate the current limitations and future directions of indole-loaded nanomedicines with a view toward clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia. Electronic address: nutanshukla14@gmail.com.
- Department of Chemistry, Dr. Harisingh Gour Central University, Sager 470003, Madhya Pradesh, India. Electronic address: ratneshdas1@gmail.com.
- Department of Chemistry, Dr. Harisingh Gour Central University, Sager 470003, Madhya Pradesh, India.
- The Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia.
- The Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia; Faculty of Chemistry, Southern Federal University, 344090 Rostov-on-Don, Russia.
- Université Paris Est Creteil, CNRS, Institut Chimie et Matériaux Paris Est, UMR 7182, 2 Rue Henri Dunant, 94320 Thiais, France. Electronic address: sabrina.belbekhouche@u-pec.fr.
Förderung
- Southern Federal University
Zitieren
APA
Shukla, N., Das, R., Chanderiya, A., Cárdenas, C. Y., Mukhanova, E., Soldatov, A., & Belbekhouche, S. (2025). Harnessing nanotechnology for efficient delivery of indole-based drugs in cancer treatment. Cancer Treatment and Research Communications, 45, 101019. https://doi.org/10.1016/j.ctarc.2025.101019
Vancouver
Shukla N, Das R, Chanderiya A, Cárdenas CY, Mukhanova E, Soldatov A, et al. Harnessing nanotechnology for efficient delivery of indole-based drugs in cancer treatment. Cancer Treatment and Research Communications. 2025;45:101019. doi:10.1016/j.ctarc.2025.101019
BibTeX
@article{Shukla2025,
author = {Shukla, Nutan and Das, Ratnesh and Chanderiya, Aayushi and Cárdenas, Carol Y and Mukhanova, Elizaveta and Soldatov, Alexander and Belbekhouche, Sabrina},
title = {Harnessing nanotechnology for efficient delivery of indole-based drugs in cancer treatment},
journal = {Cancer Treatment and Research Communications},
year = {2025},
volume = {45},
pages = {101019},
doi = {10.1016/j.ctarc.2025.101019}
}
EUVIMED